These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7595175)

  • 1. Dramatic responses to intravenous immunoglobulin in vasculitis.
    Boman S; Ballen JL; Seggev JS
    J Intern Med; 1995 Oct; 238(4):375-7. PubMed ID: 7595175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous immunoglobulin therapy in vasculitis: speculation or evidence?
    Aries PM; Hellmich B; Gross WL
    Clin Rev Allergy Immunol; 2005 Dec; 29(3):237-45. PubMed ID: 16391399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response of vasculitic peripheral neuropathy to intravenous immunoglobulin.
    Levy Y; Uziel Y; Zandman G; Rotman P; Amital H; Sherer Y; Langevitz P; Goldman B; Shoenfeld Y
    Ann N Y Acad Sci; 2005 Jun; 1051():779-86. PubMed ID: 16127015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serologic and clinical response to treatment of systemic vasculitis and associated autoimmune disease with intravenous immunoglobulin.
    Levy Y; Sherer Y; George J; Langevitz P; Ahmed A; Bar-Dayan Y; Fabbrizzi F; Terryberry J; Peter J; Shoenfeld Y
    Int Arch Allergy Immunol; 1999 Jul; 119(3):231-8. PubMed ID: 10436395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous immunoglobulin treatment in vasculitis and connective tissue disorders.
    Steinbrecher A; Berlit P
    J Neurol; 2006 Sep; 253 Suppl 5():V39-49. PubMed ID: 16998753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Intravenously applied immunoglobulin in systemic, autoimmune and vasculitis diseases in children].
    Zeman K; Cywińska-Bernas A
    Pol Merkur Lekarski; 2011 Jun; 30(180):400-4. PubMed ID: 21751547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transient and partial effect of high-dose intravenous immunoglobulin in polyarteritis nodosa.
    Kroiss M; Hohenleutner U; Gruss C; Glaessl A; Landthaler M; Stolz W
    Dermatology; 2001; 203(2):188-9. PubMed ID: 11586025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous immunoglobulins in peripheral neuropathy associated with vasculitis.
    Levy Y; Uziel Y; Zandman GG; Amital H; Sherer Y; Langevitz P; Goldman B; Shoenfeld Y
    Ann Rheum Dis; 2003 Dec; 62(12):1221-3. PubMed ID: 14644864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Preliminary results of intravenous immunoglobulins in treating patients with vasculitis].
    Antonelli A; Agostini G; Agostini S
    Clin Ter; 1992 Sep; 141(9 Pt 2):33-6. PubMed ID: 1468195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous immunoglobulin for ANCA-associated systemic vasculitis with persistent disease activity.
    Jayne DR; Chapel H; Adu D; Misbah S; O'Donoghue D; Scott D; Lockwood CM
    QJM; 2000 Jul; 93(7):433-9. PubMed ID: 10874052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ANCA anti-idiotype antibodies and the treatment of systemic vasculitis with intravenous immunoglobulin.
    Jayne DR; Esnault VL; Lockwood CM
    J Autoimmun; 1993 Apr; 6(2):207-19. PubMed ID: 8499059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of antineutrophil cytoplasmic autoantibody-positive systemic vasculitis and glomerulonephritis with pooled intravenous gammaglobulin.
    Tuso P; Moudgil A; Hay J; Goodman D; Kamil E; Koyyana R; Jordan SC
    Am J Kidney Dis; 1992 Nov; 20(5):504-8. PubMed ID: 1442764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response of livedoid vasculitis to intravenous immunoglobulin.
    Ravat FE; Evans AV; Russell-Jones R
    Br J Dermatol; 2002 Jul; 147(1):166-9. PubMed ID: 12100203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Case report: steroid sparing effect of intravenous gamma globulin in a child with necrotizing vasculitis.
    Gedalia A; Correa H; Kaiser M; Sorensen R
    Am J Med Sci; 1995 Apr; 309(4):226-8. PubMed ID: 7900746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous immunoglobulins in polyarteritis nodosa restricted to the limbs: case reports and review of the literature.
    Balbir-Gurman A; Nahir AM; Braun-Moscovici Y
    Clin Exp Rheumatol; 2007; 25(1 Suppl 44):S28-30. PubMed ID: 17428360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous immunoglobulin (IVIg) therapy in MPO-ANCA related polyangiitis with rapidly progressive glomerulonephritis in Japan.
    Muso E; Ito-Ihara T; Ono T; Imai E; Yamagata K; Akamatsu A; Suzuki K
    Jpn J Infect Dis; 2004 Oct; 57(5):S17-8. PubMed ID: 15507757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cutaneous periarteritis nodosa resistant to combined corticosteroids and immunosuppressive agents. Efficacy of treatment with intravenous immunoglobulins].
    Machet L; Vincent O; Machet MC; Barruet K; Vaillant L; Lorette G
    Ann Dermatol Venereol; 1995; 122(11-12):769-72. PubMed ID: 8729821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulsed intravenous immunoglobulin therapy in livedoid vasculitis: an open trial evaluating 9 consecutive patients.
    Kreuter A; Gambichler T; Breuckmann F; Bechara FG; Rotterdam S; Stücker M; Altmeyer P
    J Am Acad Dermatol; 2004 Oct; 51(4):574-9. PubMed ID: 15389193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous immunoglobulin as sole therapy for systemic vasculitis.
    Jayne DR; Lockwood CM
    Br J Rheumatol; 1996 Nov; 35(11):1150-3. PubMed ID: 8948304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic parvovirus B19 infection and systemic necrotising vasculitis: opportunistic infection or aetiological agent?
    Finkel TH; Török TJ; Ferguson PJ; Durigon EL; Zaki SR; Leung DY; Harbeck RJ; Gelfand EW; Saulsbury FT; Hollister JR
    Lancet; 1994 May; 343(8908):1255-8. PubMed ID: 7910276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.